Unspecified

Extract from the above information

Reduced glutathione (GSH) is a peptide naturally synthesized in human cytoplasm. It is composed of glutamic acid, cysteine and glycine, contains sulfhydryl (-SH) and is widely distributed in various organs of the body. It has played an important role in maintaining the biological functions of cells. It is the cofactor of glyceraldehyde phosphate dehydrogenase, and the coenzyme of glyoxalase and triose dehydrogenase. It participates in the tricarboxylic acid cycle and sugar metabolism in the body. This product can activate a variety of enzymes [such as sulfhydryl (-SH) enzymes, etc.], thereby promoting the metabolism of sugar, fat and protein, and can affect the metabolic process of cells; it can combine with free radicals in the body through sulfhydryl groups, and can be converted into easily metabolized acids to accelerate the excretion of free radicals, which helps to reduce the toxic side effects of chemotherapy and radiotherapy, and has no obvious effect on the efficacy of chemotherapy and radiotherapy. For example, the main mechanism for protecting renal tubules from damage by cisplatin is that the renal tubular cells contain r-glutamyl aminotransferase required for glutathione detoxification, but the renal cells do not have this enzyme, so it does not affect the cytotoxic effect of this product while protecting normal tissues and organs. It is also effective in treating radiation enteritis; it can reduce tissue damage and promote repair in patients with systemic or local hypoxemia caused by anemia, poisoning or tissue inflammation. Through transmethylation and transpropylamination reactions, GSH can also protect the liver's synthesis, detoxification, and hormone inactivation functions, and promote bile acid metabolism, which is beneficial to the absorption of fat and fat-soluble vitamins (A, D, E, K) in the digestive tract.

Reduced glutathione (GSH) is a peptide naturally synthesized in human cytoplasm. It is composed of glutamic acid, cysteine and glycine, contains sulfhydryl (-SH) and is widely distributed in various organs of the body. It has played an important role in maintaining the biological functions of cells. It is the cofactor of glyceraldehyde phosphate dehydrogenase, and the coenzyme of glyoxalase and triose dehydrogenase. It participates in the tricarboxylic acid cycle and sugar metabolism in the body. This product can activate a variety of enzymes [such as sulfhydryl (-SH) enzymes, etc.], thereby promoting the metabolism of sugar, fat and protein, and can affect the metabolic process of cells; it can combine with free radicals in the body through sulfhydryl groups, and can be converted into easily metabolized acids to accelerate the excretion of free radicals, which helps to reduce the toxic side effects of chemotherapy and radiotherapy, and has no significant effect on the efficacy of chemotherapy and radiotherapy. For example, the main mechanism for protecting renal tubules from damage by cisplatin is that the renal tubular cells contain gamma-glutamyl transpeptidase required for glutathione detoxification, but the pain cells do not have this enzyme, so it does not affect the cytotoxic effect of this product while protecting normal tissues and organs. It is also effective in treating radiation enteritis; it can reduce tissue damage and promote repair in patients with systemic or local hypoxemia caused by anemia, poisoning or tissue inflammation. Through transmethylation and transpropylamination reactions, GSH can also protect the liver's synthesis, detoxification, and hormone inactivation functions, and promote bile acid metabolism, which is beneficial to the absorption of fat and fat-soluble vitamins (A, D, E, K) in the digestive tract.